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Highlights 7 
• Biological nanoparticles play key roles in research and therapeutics. 8 
• A range of techniques are available to study such particles in terms of size and 9 
concentration. 10 
• Each technique has associated advantages and disadvantages. 11 
• Novel approaches allow the analysis of the full range of nanoparticles with a single 12 
instrument. 13 
Abstract 14 
Biological nanoparticles include liposomes, extracellular vesicle and lipid-based discoidal systems.  15 
When studying such particles, there are several key parameters of interest, including particle size and 16 
concentration.  Measuring these characteristics can be of particular importance in the research 17 
laboratory or when producing such particles as biotherapeutics. This article briefly describes the major 18 
types of lipid-containing nanoparticles and the techniques that can be used to study them.  Such 19 
methodologies include electron microscopy, atomic force microscopy, dynamic light scattering, 20 
nanoparticle tracking analysis, flow cytometry, tunable resistive pulse sensing and microfluidic 21 
resistive pulse sensing. Whilst no technique is perfect for the analysis of all nanoparticles, this article 22 
provides advantages and disadvantages of each, highlighting the latest developments in the field.  23 
Finally, we demonstrate the use of microfluidic resistive pulse sensing for the analysis of biological 24 
nanoparticles. 25 
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Introduction 29 
Nanoparticles 30 
Nanoparticle (NP) is a term which encompasses several subpopulations. Nanoparticles can be 31 
naturally occurring, for example, extracellular vesicles (EVs) released by cells across the three main 32 
groups of the phylogenetic tree: Archaea, Bacteria and Eukarya. They can also be engineered, as with 33 
viruses used for vaccines; they can be biological (for example liposomes) or non-biological (such as 34 
metal or metal-derived NPs) or a combination of both. They could also be accidental in their 35 
production, such as exhaust fumes. In this review, we will use the term “nanoparticle” to refer to 36 
extracellular vesicles, liposomes and nanodisc systems, e.g. styrene maleic acid lipid particles 37 
(SMALPs).   38 
Whilst the international standards organisation (ISO)[1] defines nanoparticles as ranging in size from 39 
1 to 100nm, it is generally accepted that biological nanoparticles may be larger than this within the 40 
sub-micron range. Due to their size, NPs have a larger surface area to volume ratio when compared 41 
to bulk materials, which give them interesting physical properties. Their size and composition can 42 
make them challenging to study experimentally. 43 
Extracellular vesicles 44 
Extracellular vesicles (EVs) are membrane-surrounded structures released by healthy, apoptotic and 45 
diseased cells. They were first described in 1967 by P. Wolf [2] and are found in most biological fluids. 46 
They are a highly heterogeneous population which vary in size, content, and mechanism of formation 47 
[3]. Their origin can also be used to classify them further. The field acknowledges three distinct 48 
subpopulations: apoptotic vesicles (30nm-5m), microvesicles (100nm-1µm) and exosomes (30nm-49 
100nm) (Figure 1). Exosomes are initially formed inside multivesicular bodies (MVBs) and are further 50 
released through exocytosis into the extracellular environment. Alternatively, microvesicles and 51 
apoptotic bodies are produced through budding of the plasma membrane.  52 
Apoptotic cell-derived EVs (ACdEVs) encompass apoptotic bodies, apoptotic microvesicles and 53 
exosome-like vesicles. Evidence suggests that ACdEV biogenesis seems to be more complex as they 54 
can be formed through membrane protrusions termed apoptopodia [4], or through plasma membrane 55 
blebbing as mentioned previously. However, as little is reported in the literature regarding ACdEVs, 56 
other novel mechanisms of biogenesis are worth investigating.   57 
 58 
Figure 1 Extracellular vesicles formation and different subpopulations. Healthy and diseased cells 59 
release two mains forms of EVs named exosomes and microvesicles. They are released through the 60 
exocytosis of multivesicular bodies (MVBs) and via plasma membrane shedding. Apoptotic cells release 61 
ACdEVs of various size through membrane protrusion, membrane blebbing and other mechanisms. 62 
Green vesicles represent exosome-like ACdEVs. 63 
It was first believed that EVs were cellular debris, but subsequent research has shown they contain a 64 
specific subset of proteins, mRNAs, miRNAs, and lipids rather than random cellular components [5]. It 65 
has been demonstrated that EVs play a major pathophysiological role in various biological process 66 
(apoptotic cell clearance, infection, immune response, antigen presentation [6]). They function to 67 
transport and deliver cargo molecules between cells [7]. This EV-mediated intercellular 68 
communication (IC) exists in healthy tissues and when altered, can lead to a variety of diseases, namely 69 
autoimmune diseases and cancer. In the past few decades, EVs have received a great deal of interest 70 
for their diagnostic and therapeutic potential [8].  71 
Liposomes 72 
Liposomes were first discovered by Bangham and his co-workers in 1961 [9], and can be described as 73 
spherical artificial vesicles of various lamellarity: usually one or two phospholipid bilayers. Liposomes 74 
are formed spontaneously, but many different methods of preparation exist. These can be divided 75 
between passive or active loading techniques. The most common passive techniques are mechanical 76 
dispersion, solvent dispersion or detergent removal, such as sonication and extrusion [10]. Similar 77 
structures can also be formed from polymers (sometimes referred to as polymersomes) [11].  78 
Conventional liposomes are commonly made of ester phospholipids such as phosphatidylcholine. A 79 
new generation of liposomes have modified formulations in order to try to overcome instability issues 80 
and enhance specificity [12]. For example, archeasomes contain one or more lipids found in 81 
archeobacterial membranes that offer higher stability because of di-ether linkages [13]. Additionally, 82 
virosomes are a combination of liposomes with virus-derived envelope proteins, allowing the fusion 83 
of the virosomes with the target cell [14]. Finally, novasomes are paucimellar vesicles formed of two 84 
to seven bilayer membranes commonly used in cosmetics [15].  85 
Liposomes can be loaded with different drugs and or molecules and used as drug carriers to deliver a 86 
range of active pharmaceutical ingredients (API) to a site of action for therapeutic and diagnostic 87 
purposes [16]. This liposomal encapsulation technology (LET) can involve drug molecules, gene 88 
therapies and bioactive agents. Hydrophobic API can be incorporated into the phospholipid bilayers, 89 
whereas hydrophilic API can be encapsulated inside the aqueous centre. LET has been shown to 90 
increase the stability and decrease the toxicity of the active molecules making it more efficient [17]. 91 
Different types of liposomal drug delivery system (DDS) exist [18], for example, by coupling the 92 
liposomes to targeting ligands to increase the specificity. These carriers are most valuable because of 93 
their biocompatibility and non-immunogenicity [19].  94 
Another use for liposomes is their relevance as a biological model [20],[21]. They can be used to mimic 95 
both extracellular vesicles and cells, offering a non-invasive alternative to study biological processes 96 
and test drugs. Their composition, size and charge can be tuned to make a highly accurate model.  97 
Disc systems 98 
In membrane protein research, proteins often have to be isolated from the membrane in order to 99 
study them. This has often resulted in the use of detergents to solubilise the membrane, and therefore 100 
the protein, into detergent micelles. Throughout the past decades, it has become more apparent the 101 
native lipid environment surrounding the protein plays numerous roles in the structural stability and 102 
functionality of the protein. Hence, alternatives to detergents are advantageous [22].   103 
Membrane scaffold proteins (MSPs) are one of the alternatives to a purely detergent-based isolation 104 
system. Bayburt et al., 2002 [24] first described the formation of bilayer patches surrounded and 105 
stabilised by a ring of amphipathic helical protein, termed membrane scaffold proteins. The process 106 
of forming these patches was described as a self-assembly mechanism whereby lipids, MSPs, and 107 
detergent were added to protein-detergent micelles forming particles of around 10nm in size [25] 108 
(Figure 2).  109 
Figure 2 Schematic demonstrating the formation of MSP nanodiscs. A protein is isolated from the 110 
membrane via detergent solubilisation. A mixture of lipids and membrane scaffold proteins (MSPs) are 111 
added to the protein-detergent micelle solution, this results in the self-assembly of MPS encapsulated 112 
protein-lipid nanodiscs. 113 
A more recent approach is the use of styrene-maleic acid (SMA) copolymers and derivatives to isolate 114 
membrane proteins in a nanometer-sized disc, known as SMA lipid particles (SMALPs) (Figure 3). The 115 
technique was first described in 2009 by Knowles et al. [26] and has the distinct advantage that the 116 
protein is extracted directly from the membrane without the need for detergent, and therefore 117 
maintains a near-native lipid environment, which is beneficial for downstream research [26]. 118 
Figure 3 Schematic of SMALP encapsulated nanodiscs. SMA copolymers punch holes in the membrane 119 
encapsulating anything that is present, i.e. membrane proteins (protein of interest as well as other 120 
proteins) or ‘empty’ lipid only discs.  121 
The greatest challenge of single NP based isolation and analysis is still the size of the NPs, which are 122 
below the reach of conventional detection methods [27]. In this review, we will present the main 123 
methods for NP analysis and their limitations, focusing on single particle-based quantification and size 124 
profiling. Finally, an advancement in NP analysing technology will be introduced as an alternative to 125 
study NPs with preliminary data presented.  126 
Conventional methods for NP analysis 127 
Common isolation methods for NPs include; ultracentrifugation (UC) and precipitation alongside size-128 
, immunoaffinity capture-, and microfluidic-based techniques [28]. Microfluidic isolation is a promising 129 
field, which offers miniaturisation of conventional techniques, quicker purification times and 130 
improved resolution while enabling a continuous separation of the NPs. Following isolation using any 131 
approach, it is often desirable to analyse the size of the NPs to ensure either efficient separation or to 132 
define the nature of the sample. 133 
Electron microscopy (EM) 134 
Conventional optical microscopes cannot be used due to NPs being below the diffraction limit of 135 
visible light (200nm). Traditionally, the only way to visualise NPs via microscopy is by using the shorter 136 
wavelength and higher frequency of an electron microscope. As the wavelength of an electron can be 137 
up to 100,000 times shorter than that of visible light photons, electron microscopes have a higher 138 
resolving power that can reveal the structure of smaller objects, i.e. in the nanoscale. The first electron 139 
microscope was built in 1931 by Ruska and Knoll. Nowadays, two types of electron microscopes exist 140 
Scanning EM (SEM) and Transmission EM (TEM) (Figure 4). 141 
Figure 4 Simple schematic of the most common EM techniques. Scanning electron microscopy 142 
determines information about the sample surface. Transmission electron microscopy sends electrons 143 
through the heavy metal coated sample, acquiring structural information. Cryo-transmission electron 144 
microscopy utilises freezing of the sample to retain native structural information. 145 
SEM is an electrical conductivity-based EM where the electron beam is focused onto the surface of 146 
the samples, scanning it line by line. A detector simultaneously counts the scattered secondary 147 
electrons. The images acquired by SEM only allow visualisation of the surface of the specimen, but 148 
SEM can also provide 3-dimensional (3D) images. However, this method offers a lower resolution than 149 
TEM [29]. 150 
TEM is an electron emission-based EM for thin samples (~100nm). Here, the beam of accelerated 151 
electrons passes through the samples. The detector is below the sample retrieving the electron to 152 
provide structural information. The entire electron path through the column must be under vacuum. 153 
High-resolution TEM (HRTEM) is now able to provide a resolution below 0.5 angstroms [30]. However, 154 
this resolution is limited to non-biological samples, regarding lipidic nanoparticles the resolution of 155 
~1.5 angstroms is more accurate [31].TEM can have variants such as immune-EM, Cryo-EM (single-156 
particle and tomography), 3D-EM and conventional TEM. 157 
For conventional TEM, the thin sections are coated with heavy metals in order to obtain a better 158 
contrast and to visualise the lipid bilayer [32]. Depending on where the section was made, the 159 
diameter can differ. The morphology of the whole particle thus remains uncertain. Fixatives can be 160 
added to improve the sample retention. This method is a rapid way of confirming the presence of NPs 161 
in a sample. 162 
The least invasive technique is cryo-TEM, where the sample is frozen using a cryogen (liquid ethane or 163 
propane) (Figure 4). Upon rapid freezing, a thin liquid film of the buffer is transformed into an 164 
amorphous solid, allowing the object beneath to be observed in the native frozen-hydrated state. The 165 
immediate freezing of the sample allows no time for crystal formation, removing the need to use 166 
fixative and heavy metals. The sample is then transferred in a cryo-electron microscope and observed 167 
at low temperature (-170 °C). The lipid bilayer appears as two thin dark lines because of the 168 
phosphorous atoms (the heaviest) scattering more electrons [33]. 169 
Phenotyping of EVs can be performed using cryo-TEM combined with immune-gold-labelling. Gold 170 
particles provide high contrast in EM thanks to their large electron scattering properties (i.e. plasma 171 
EVs exposing phosphatidylserine (PS) labelled with annexin V (An-V) conjugated with gold particles) 172 
[34]. Additionally, electron tomography (ET) can be used for 3D reconstruction based on 2-173 
dimensional pictures taken at many different angles creating a tilt series. This can be combined with 174 
cryo-TEM by creating electronic slices as thin as 1nm through the reconstructed 3-D volume [35]. The 175 
details are much finer compared to cryo-EM alone and allow discrimination of vesicles spatially below 176 
or inside another one.  The angles of the image do not yet permit a fully 3D structure due to an artefact 177 
that is referred to in the literature as “the missing wedge” [28, 29].  178 
TEM has some potential disadvantages for particle analysis including possible radiation damage to the 179 
sample such as re-conformation and de-crystallisation to the breaking of atom bonds, removal of side-180 
chains and in general a loss of mass [38]. 181 
Atomic force microscopy (AFM) 182 
Atomic force microscopy (AFM) is a type of scanning force microscopy (SFM) developed in the 1980s 183 
by Binning, Quate, and Gerber [39]. Typically, a near-horizontal cantilever is used with a “nanofiber” 184 
tip facing towards the sample. Lasers are then reflected off the back of the cantilever to track the 185 
change in its displacement, which depending on its mode of operation, provides different information 186 
(Figure 5). 187 
 188 
Figure 5 Schematic representation of Atomic Force Microscopy. The cantilever is in contact with the 189 
sample and the sample stage (piezoelectric (PZT) scanner) moves the x, y, and z position. A laser 190 
monitors the position of tip with feedback via a photodiode to the piezoelectric scanner to move the 191 
stage z-position to build a topological image at atomic resolution. 192 
There are three modes of AFM; the first mode is contact-based, where the sample stage is positioned 193 
to provide a small upwards deflection of the tip when contact occurs. The sample is then moved along 194 
the x- and y-axis. As the topology of the sample changes so does the level of cantilever deflection, 195 
some operate by simply tracking the height of the cantilever in absolute terms and generating the 196 
topology from this [40]. In others, the system will for each x and y co-ordinate aim to deliver a 197 
consistent level of deflection, and the required changes in the samples z position will generate the 198 
topological map.  199 
The second mode is non-contact. Here instead of an upwards deflection, a downwards deflection is 200 
observed. This is due to atomic forces, e.g. Van der Waals on this scale interacting with the cantilever, 201 
pulling it towards the sample [41]. Again, the concept is to maintain a consistent deflection and 202 
generate a topological map through record stage positioning.  203 
There is a third non-contact mode. This involves the cantilever being oscillated at very high 204 
frequencies. As the tip gets close to the sample, either atomic forces or physical interactions, often 205 
with a layer of moisture present, leads to a dampening of the oscillation frequency. A consistent level 206 
of damping is required to generate the topological map [42]. 207 
Some advantages are that AFM can be operated in ambient conditions and often requires no special 208 
preparation of the sample. The sample sizes are often small, e.g. <200nm squared. Advances in 209 
piezoelectrics and control systems allow for near real-time scanning to generate videos, particularly 210 
useful for studying biological samples [43],[44]. Improved methods are always being developed, e.g. 211 
Transverse dynamic force microscopy (TDFM) which uses a vertical cantilever [45]. 212 
Dynamic light scattering (DLS) 213 
Dynamic light scattering (DLS) is one of the most common and simple techniques used in the analysis 214 
of particle size distribution [46]. DLS is a measure of time-dependent fluctuations in the scattered light 215 
of particles undergoing Brownian motion (diffusion caused by random collisions with solvent 216 
molecules). A particle’s hydrodynamic diameter is calculated as a function of the diffusion coefficient. 217 
Where the diffusion coefficient is inversely proportional to the particle size according to the Stokes-218 
Einstein equation (Figure 6). This calculation assumes that all particles are spherical, reporting an 219 
equivalent particle diameter which can be disadvantageous for studying discoidal systems. 220 
Figure 6 Schematic of Particle Size Analysis by Dynamic Light Scattering. A laser illuminates particles 221 
undergoing Brownian motion in a sample. A photodetector measures the fluctuations in the intensity 222 
of scattered light over a time period. Stokes-Einstein’s equation is used to calculate the hydrodynamic 223 
diameter of the particles. 224 
DLS can analyse particles ranging from 0.5 to 10,000nm dependent on the instrument and can analyse 225 
as little as 45µL of the sample, although common practice is to use a standard size cuvette which 226 
requires around 500µL for analysis. DLS also uses Rayleigh’s approximation, where the intensity, I, of 227 
scattered light is proportional to the sixth power of the particle diameter, d: I ∝ d6 (i.e. a particle of 228 
100nm will scatter light with a million times the intensity of a 10nm particle)[46],[47]. This means that 229 
DLS has an inherent bias towards larger particles and therefore, a tendency to oversize particles in a 230 
polydisperse mixture and as such, it is not suitable for highly polydisperse samples. 231 
Nanoparticle tracking analyser (NTA) 232 
Nanoparticle tracking analysis (NTA) can be used for various applications, including but not limited to 233 
vesicles, exosomes, and proteins [48]. NTA uses the same underlying principle as DLS as it measures 234 
time-dependent fluctuations in scattered laser light of particles undergoing Brownian motion to 235 
determine their hydrodynamic radius. Where NTA differs is how it detects the scattered light. NTA 236 
uses a laser beam to illuminate particles, and the scattered light is easily visualised with a conventional 237 
microscope equipped with a 20x objective lens. Particle movement, i.e. scattered light, is then 238 
recorded with a light-sensitive charged-coupled device (CCD) or CMOS camera, arranged at a 90° angle 239 
to the irradiation plane [49]. The camera operates at 30 frames per second (fps), capturing a video file 240 
of the particles moving under Brownian motion. The software tracks many particles individually and 241 
using the Stokes-Einstein equation calculates their hydrodynamic diameters (Figure 7) [50]. As NTA is 242 
capable of tracking individual particles, the concentration of particles within a sample can be 243 




Figure 7 Schematic Representation of Particle Size Analysis by Nanoparticle Tracking Analysis. A 248 
laser illuminates particles undergoing Brownian motion in a sample. Particle movement i.e. scattered 249 
light is then recorded with a light-sensitive charged-coupled device (CCD) or CMOS camera. Software 250 
tracks individual particles and uses the Stokes-Einstein equation calculates their hydrodynamic 251 
diameters. 252 
NTA is reported to size particles between 10 and 1000nm at a concentration range of 1E+06 to 1E+09 253 
particles.mL-1; however, this is sample and system configuration dependent [50]. For samples (such as 254 
EVs), where the refractive index (RI) of the particle is close to the RI of the electrolyte it is suspended 255 
in, the detection resolution is compromised, resulting in a restricted size analysis range and unreliable 256 
concentration determination [51]. Like DLS, NTA also has restricted resolution for polydisperse 257 
samples due to Rayleigh’s approximation, making it difficult to detect and track small particles [46].  258 
Conventional Flow Cytometry (FCM) 259 
Flow cytometry (FCM) is a laser-based technology developed for high throughput, multiparametric 260 
analysis of individual particles (e.g. cells). It allows the analysis of thousands of cells per second. 261 
However, in order to be detected, particles need to scatter light and/or induce fluorescence. NPs are 262 
much smaller than the cells for which flow cytometry was designed. Conventional FCM has a lower 263 
detection limit for polystyrene beads between 200 and 500nm [52]; consequently, the detection of 264 
NPs remains a challenge. Recently, dedicated small particle high-resolution flow cytometry (HRFCM) 265 
can offer a better resolution down to 40nm [53]. 266 
Cells and NPs are guided through a laser beam. The first detector is parallel to this beam and measures 267 
forward scattered light (FSC). The other detector is perpendicular to the beam and measures the side 268 
scattered light (SSC). FSC is used to look at the specimen size, whereas SSC is used to look at its 269 
granularity (Figure 8). The smaller the particle, the less the light scatters and the more background. 270 
FSC depends on the radius, the illumination wavelength, the refractive index and the light collection 271 
angle [54]. Thus, for an identical size, particles can have various refractive indices, resulting in a 272 
different scattering (Figure 9A). For the analysis of EVs, it is better to use silica beads for calibration, 273 
as EVs refractive index is closer to that of silica beads than polystyrene beads.  274 
Figure 8 Schematic Representation of Particle Analysis by Flow Cytometry. A particle suspension 275 
enters the flow cell where the particles are aligned into a single stream and pass through a focused 276 
laser-beam. The resultant signal provides information on their size/granularity based on their forward 277 
and side scatter and the fluorescent intensities (*if fluorescently labelled) of each particle.  278 
Fluorescent detection of surface proteins can also be achieved as long as the labelling of the NP is 279 
bright enough to discriminate NPs from the optical and electronic noise. To do so, the light scatter 280 
threshold can be modified, or the excess of label can be removed using a density gradient. Focusing 281 
on EVs, the fluorescence trigger can be used as long as the antigen is abundant enough to allow 282 
detection. This can be an issue for smaller particles with fewer copies of the antigen of interest [55]. 283 
Thus, sensitivity limits should be kept in mind when using fluorescently-labelled antibodies. 284 
The concentration of the particles can have an important impact on both scatter and fluorescence 285 
[56]. If the concentration is too high, it will result in a swarm detection (Figure 9B). This occurs when 286 
two or more particles are in the measurement volume when the data acquisition is triggered, resulting 287 
in multiple NPs counted as a single event [57]. In order to have a better single NP detection, the 288 
samples need to be carefully diluted to an appropriate particle concentration. FCM offers a great 289 
possibility for single NP based analysis as long as there is a standardisation of the sample preparation 290 
as well as the appropriate instrument calibration. 291 
Figure 9 Principles of flow cytometry for NP analysis A. Effect of the refractive index (RI) of different 292 
nature of nanoparticles on the light scattering. B. Representation of particle flowing: swarm detection 293 
in opposition to a single event detection. Individual seagull representing an individual particle. 294 
Tunable resistive pulse sensing (TRPS) 295 
Tunable resistive pulse sensing (TRPS), previously known as scanning ion occlusion spectroscopy (SIOS) 296 
[58], is suitable for biological and inorganic NP size, concentration and charge analysis. The equipment 297 
most largely associated with TRPS is produced by Izon Science Ltd and can be referred to as qNano.  298 
TRPS requires a nanosized stretchable pore that separates two conductive fluid compartments. After 299 
applying a voltage across the nanopore, a current is established which is disrupted by the movement 300 
of particles through the nanopore. When a particle moves through the opening, it decreases the flow 301 
of ions through the nanopore, causing a transient current decrease known as a blockade event [59]. 302 
The amplitude of this event provides information for the size profiling of the particle. The number of 303 
blockades throughout time gives information about the concentration (Figure 10). NP measurement 304 
using TRPS requires an initial run with a calibration sample of known diameter and concentration, 305 
usually polystyrene beads of a modal size appropriate to the range of interest [41,42]. Samples and 306 
calibration should ideally be performed in the same buffer, which can cause issues with biological 307 
samples. Spiking the sample directly with calibration beads offers an alternative calibration method.  308 
Figure 10 Principle of the TRPS technique to measure the diameter and concentration of 309 
nanoparticles. The magnitude of the blockade event gives information on the hydrodynamic diameter, 310 
whereas the number of blockades over time gives information on the concentration.   311 
The size range of the nanopores can be tuned depending on the NPs of interest. Currently, the smallest 312 
nanopore is the NP100 that has a size range of 70-200nm. However, the full range of manufactured 313 
tunable pores extends from 70nm to 10m. The measurement settings are flexible between each user. 314 
Different parameters can be adjusted in order to have the best measurement conditions, such as the 315 
nanopore stretch, the applied voltage and the pressure. The same parameters must be used between 316 
measurements to ensure the reproducibility of the data. A total of 500 particles or more is then 317 
counted per measurement. The TRPS technique provides a particle-by-particle analysis of the size and 318 
concentration using tunable nanopores. However, it can be challenging due to the size heterogeneity 319 
of the samples that can often lead to the blockage of the nanopore; this can be especially true for 320 
biological samples.  321 
 322 
Table 1 Comparison of the conventional techniques used to characterize the size and concentration 323 
of NPs. 324 
 325 
Figure 11 Size ranges for particle analysis of discussed techniques. 326 
 327 
TECHNIQUE ADVANTAGES DISADVANTAGES 









Highly time consuming 
AFM Atomic resolution 
Morphology/ surface roughness 
Sample preparation 
Expensive equipment 
Specific training and expertise 
Highly time consuming 
DLS Quick 
Easy to use 
Relatively inexpensive 
High throughput 
Low resolution in polydisperse 
samples 
Tendency to oversize particles due to 
Rayleigh’s approximation of scattered 
light 
NTA Quick 
Easy to use 
Relatively inexpensive 
High throughput 
Data bias dependent on user settings 
Dependent on refractive index  
Low resolution in highly concentrated 
polydisperse samples due to 
Rayleigh’s approximation. 
Moderately time consuming 
FCM Full NP diameter range 
High throughput   
Multiparametric analysis 
Low resolution  
Risk of swarm detection 
Low sensitivity 
no information about morphology 
Moderately time consuming 
TRPS Inexpensive 
Reusable pore 
Single particle-based analysis 
High throughput 
Easily clogged nanopores 
Calibration required 
Moderately time consuming  
Required standardisation 
Each technique for NP characterisation has different limitations and advantages (Table 1 and Figure 328 
11) [62]. Thus, it is often recommended to combine several techniques instead of choosing one 329 
method, as there is no standard procedure for the characterisation of NPs to date. 330 
Recent Advances in Nanoparticle Analysis 331 
Microfluidic resistive pulse sensing 332 
Microfluidic resistive pulse sensing (MRPS) is a promising advancement in the resistive pulse sensing 333 
techniques originally described in the Coulter Principle over half a century ago [63]. The last decade 334 
has seen advancement in the form of TRPS (see the previous section). Although TRPS has pushed the 335 
limits of size detection of the resistive pulse sensing (RPS) technique, it still has limitations which need 336 
to be addressed for research to progress. In recent years there has been rapid development in the 337 
manufacturing of microfluidic chips and devices. An American company, Spectradyne, has utilised this 338 
research to develop an RPS instrument with patented microfluidic technology, the nCS1 [64]. 339 
The microfluidic technology in question is a series of pre-calibrated, single-use, low volume 340 
microfluidic cartridges. Each cartridge has a distinct size and concentration range (Figure 12). This has 341 
the benefits of making the technique an absolute method, i.e. no need for calibration material, the 342 
disposable microfluidic cartridges also dramatically reduce the risk of sample cross-contamination, 343 
with the added advantage of only requiring 3µL of sample to gain reliable, reproducible, statistically 344 
significant results. 345 
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Figure 12 nCS1 Cartridge map denoting the size and concertation ranges. 347 
 348 
 349 
The principle of the technique is essentially the same as that described by Wallace Coulter [63], 350 
whereby, a voltage is applied across an aperture (hole) submerged in an electrolyte, as a particle 351 
passes through the aperture (also termed a nano-constriction) the displacement of the electrolyte 352 
causes a voltage drop which is proportional to the size/volume of the particle, enabling its 353 
hydrodynamic diameter to be calculated [63],[65],[66]. This allows the user to obtain analytical data 354 
for individual particles making the technique highly precise. 355 
The microfluidic cartridge of Spectradyne’s nCS1 also significantly reduces one of the major issues of 356 
the RPS technique, which is aperture blockages by incorporating a sample pre-filter embedded within 357 
the microfluidic cartridge. The only drawback with the incorporation of this pre-filter is overcoming 358 
the surface tension in the smallest (TS-300/-400) size cartridges. Spectradyne recommends the 359 
addition of a surfactant (polysorbate-20/ Tween-20) at 1%(v/v) to the sample or 0.1%(w/v) bovine 360 
serum albumin (BSA) as a wetting agent where surfactant cannot be used (i.e. with lipidic samples). 361 
The technology also overcomes some of the more technical aspects of the technique, such as 362 
distinguishing agglomerated particles from monodisperse particles. It does this in the form of filters 363 
applied to the data with parameters specific to each of the different sized cartridges, such as transit 364 
time, the time it takes the particle to pass through the aperture, and symmetry.  365 
Analysis of nanoparticles using the nCS1 366 
To test the capabilities of the instrument, a polydisperse sample of polystyrene size standards 367 
(Nanospheres) were analysed (Figure 13A). A broad range of Nanospheres were used (see Figure 13B) 368 
this was to test the accuracy of the instrument over multiple size cartridges. The Nanospheres were 369 
used at an approximate concentration of 4.2E+8 particles.mL-1, i.e. a total concentration of 2.52E+9 370 
particles.mL-1 in the polydisperse sample, this is in line with the acceptable concentration range for 371 
both the TS-400 and TS-2K cartridges used in the analysis. Approximately 2500 particles were analysed 372 
with default cartridge filters applied (Table S1); the subsequent data was analysed graphically by 373 
determining size ranges for Gaussian analysis/fit (Table S2). 374 
Figure 13 Analysis of a polydisperse polystyrene size standard sample using the nCS1. A. Size 375 
distribution data demonstrating clear separation of peaks corresponding to the nominal size range of 376 
the polystyrene standards, the TS-2K cartridge perfectly overlays with the TS-400 cartridge at 303nm 377 
however demonstrates a broader distribution. B. Schematic demonstrates the size standards used in 378 
the polydisperse mix and the theoretical coverage of the cartridges. 379 
The data demonstrates that the nCS1 is capable of discerning multiple peaks in a single polydisperse 380 
sample. The TS-400 coverage range starts at 65nm; therefore, the resolution of the 60nm Nanosphere 381 
is hindered, resulting in a slight oversizing of the particle (NanosphereTM NIST traceable certified 382 
diameter of 60±4nm), these data would be best captured using a TS-300 cartridge which has a lower 383 
detection threshold of 50nm. The other peak that demonstrated variability was the 1000nm peak; this 384 
showed a broad peak with a mean of 873.3nm (Figure 13, Table S1). The remaining discernible peaks 385 
fall within their certified mean diameter (provided on the safety data sheet), demonstrating the 386 
accuracy/resolution of the nCS1.  387 
Analysis of Extracellular vesicles using the nCS1 388 
Following analysis of the polystyrene size standards, we sought to test the instrument's capabilities at 389 
detecting a biological sample. Extracellular vesicles derived from apoptotic Jurkat cells were analysed 390 
for both size range and concentration. The apoptotic cell-derived EVs (ACdEVs) were isolated using 391 
centrifugation at 2000xg, and therefore it was suspected that the EVs could vary greatly in size; as 392 
such analysis using both a TS-300 and TS-900 was conducted. The analysis was conducted without the 393 
recommended surfactant (polysorbate-20) over concern that it could cause damage/ change the 394 
integrity of the EVs. Acquisition with the TS-900 demonstrated a continuous size distribution with a 395 


















































Figure 14). Analysis across the entire TS-900 detection range (130-1000nm) reported a total of 2146 398 
particles analysed in a time period of three minutes 30 seconds, demonstrating the high throughput 399 
capacity of the instrument. The concentration of particles across this range was calculated at 1.1E+08 400 
particle.mL-1, with a D10, D50, and D90 (corresponding to 10%, 50%, and 90% of particles in the 401 





































































































Figure 14 ACdEV analysis using the nCS1. 3µl of ACdEVs (Jurkat cells) in phenol-red free RPMI-1645 407 
were analysed using a TS-900 cartridge on the nCS1. Approximately 2000 events/particles were 408 
analysed and demonstrate a size distribution with a higher concentration of EVs at the lower detection 409 
threshold. 410 
ACdEV analysis using the TS-300 cartridge was relatively unsuccessful with only a few (<100) 411 
discernible particles (data not shown). This did not acquire enough data for confident reporting of the 412 
size distribution. The lack of apparent particulate is surmised to be due to one of two reasons; the lack 413 
of surfactant in the sample and therefore a lack of wetting agent for the cartridge prefilter, or, the 414 
sheer concentration of particles/EVs larger than the aperture being retained in the prefilter and 415 
saturating it, and therefore severely reducing the flow of smaller particles. These hypotheses form 416 
part of ongoing investigations to identify an alternative to detergent as a wetting agent and to 417 
determine if pre-filtering for broad distributions is required. Nevertheless, MRPS shows great promise 418 
for the analysis of lipidic nanoparticles. 419 
Conclusions 420 
There are a wide variety of techniques for studying the size and concentration of lipidic NPs. Each 421 
approach has advantages and disadvantages, so careful thought is required to determine the correct 422 
technique for a particular sample. This is particularly true when a sample is highly polydisperse and 423 
may even contain particles outside of the nano range. This article illustrates the benefits and 424 
drawbacks of the most commonly-used approaches for analysing NPs and highlights the promising 425 
new technique of MRPS. It is nearly always advantageous to apply multiple approaches to a particular 426 
sample to enable the most complete analysis to be performed. 427 
Material and methods 428 
Cell lines and culture 429 
Jurkat T cell line, derived from an acute T cell leukaemia patient, were cultured at a density of 5E+05 430 
cells.mL-1 in RPMI 1640 medium (Sigma, Aldrich, UK) supplemented with 10% (v/v) FBS, 100 µg.mL-1 431 
penicillin/streptomycin, and 2mM glutamine. Cells were passaged every two to three days and 432 
maintained at 37°C, 5% v/v CO2.  433 
EVs production 434 
Jurkat cells were washed with PBS and resuspended in serum-free and phenol red-free RPMI-1640 435 
(Sigma, Aldrich, UK) at a density of 4E+06 cells.mL-1. Cells were then irradiated with a UV-B dose of 30 436 
mJ.(cm2)-1 using the UVP chromato-vue C71 cabinet. Analysis of apoptosis was performed using 437 
annexin V-FITC / propidium iodide (PI) staining kit (BioLegend, San Diego) to confirm the cell death by 438 
flow cytometry (CytoFLEX S, Beckman Coulter, USA).  439 
Measurement on nCS1 440 
• Nanosphere analysis 441 
National Institute of Standards and Technology (NIST) traceable NanosphereTM size standards 442 
(ThermoScientific) were suspended in Isoton-II solution with 1% Tween-20, filtered to 0.22 µm using 443 
a PES syringe filter, to create a polydisperse mixture (60, 100, 202, 303, and 1000nm) with a final 444 
concentration of ~2.52E+09 particles.mL-1. 3µL of sample was loaded into two different cartridges, TS-445 
400 and TS-2K, in order to visualize the different sized nanospheres.  446 
• ACdEV analysis 447 
3µL of ACdEVs suspended in phenol-red free RPMI (Sigma, Aldrich, UK) was loaded into TS-300 and 448 
TS-900 cartridges and loaded into the machine for analysis. 449 
The cartridge mould I.D. and date has to be inserted into the software, this provides the auto analysis 450 
engine with the parameters of the cartridge loaded, the machine then automatically primes the 451 
cartridge and collects the data. The machine will collect and analyse 10-second analysis windows until 452 
you either manually stop the runs or enter stop acquisition parameters, such as number of particles, 453 
in the auto-analysis run window. 454 
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